Trials Sponsors Conditions Drugs Pricing

Conditions

Premenstrual Tension

Outcome Measures

Primary Outcomes (2)

Visual analogue scale (VAS)
Visual analogue scale (VAS): Degrees of menstrual pain will be assessed using a VAS for all participants in both groups (A\&B) before and after treatment, which is a method of representing .participants pain on a 10 cm linear scale. A score of zero mean "a very low degree of pain" and 10 mean "a very high degree of pain"
assessment will be take 12 weeks
Menstrual Distress Questionnaire (MDQ)
Menstrual Distress Questionnaire (MDQ): The subjects decreased activity, lower back pain, tension or anxiety, breast tenderness, and headaches will assess for all participants in both group before and after treatment using Menstrual Distress Questionnaire (MDQ) .Each item will be score on a 5-point likert scale ,with 1 being "no pain at all" follow by "mild pain", "moderate pain", "slightly sever pain" ,and "extremely severe pain.
assessment will be take 12 weeks

Study Arms (2)

medical treatment

EXPERIMENTAL

Control group:Will be consisted of 25 females suffering from PMS will receive medical treatment in form of vit, B6, ca supplements and minerals (vitatron), once daily(1capsule), for 12 weeks.

Other: dietary supplement ,electronic treadmill ,DASH diet.

the same medication, in addition to DASH diet and aerobic exercise

EXPERIMENTAL

Study group: Will be consisted of 25 females suffering from PMS will Receive the same medication as in group (A) in addition to the DASH diet and aerobic exercise for 30 minutes,3 times/week,for 12 weeks.

Other: dietary supplement ,electronic treadmill ,DASH diet.

Interventions

dietary supplement ,electronic treadmill ,DASH diet.Other

Control group Will be receive medical treatment for 12 weeks. Study group Will be receive the same medication as in control group in addition to DASH diet and aerobic exercise for 12 weeks.

medical treatmentthe same medication, in addition to DASH diet and aerobic exercise

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age15 Years - 25 Years

Sexfemale

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

Fifty adolescent females were diagnosed with premenstrual syndrome.
Their age will be ranged from 15-to 25 years (3 years post-puberty).

Sponsors & Collaborators

Cairo University
Otherlead

MeSH Terms

Conditions

Premenstrual Syndrome

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Azaa Barmoud, professor

CONTACT

01008410312 drazzakassab@yahoo.com

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: INVESTIGATOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: specialist physical therapist at Al Delangat Hospital

Study Record Dates

First Submitted

May 24, 2022

First Posted

May 27, 2022

Study Start

June 1, 2022

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Primary Completion

EFFECT OF DASH DIET AND AEROBIC EXERCISES ON PREMENSTRUAL SYNDROME

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

medical treatment

the same medication, in addition to DASH diet and aerobic exercise

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (2)

medical treatment

the same medication, in addition to DASH diet and aerobic exercise

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record